Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital [Yahoo! Finance]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Yahoo! Finance
LA JOLLA, Calif., April 30, 2024 BUSINESS WIRE Enlaza Therapeutics , the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further develop Enlaza's proprietary covalent protein technologies and to support advancement of wholly owned pipeline programs to the clinic. The financing was led by the Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors: Frazier Life Sciences, Avalon Ventures, Lightspeed Venture Partners, and Samsara BioCapital. The financing also includes new investors: Amgen Ventures, Regeneron Ventures, Bregua Corporation, Pappas Capital, and Alexandria Venture Investments. Concurrent with the financing, Stephen Squinto, Ph.D., Chief Investment Officer (CIO) of the Life Sciences group of J.P. Morgan Private Capital, was named to the Board of Directors. "We are thrilled to close this financing with a group of new and existing in
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- Jamie Dimon teases that his departure from JPMorgan is getting closer, saying timeline is ‘not five years anymore' [Fortune]Fortune
- JP Morgan Payments adds Studio Science to payments partner network [Yahoo! Finance]Yahoo! Finance
- Top-ranked analyst declares JPMorgan ‘the Nvidia of banking' after it spends $17 billion on tech in a single year [Yahoo! Finance]Yahoo! Finance
- JPMorgan investor day, benefits of Biden tariffs on solar: Market Domination [Yahoo! Finance]Yahoo! Finance
- Asian Stocks Look Mixed as Traders Await Nvidia: Markets Wrap [BNN Bloomberg (Canada)]BNN Bloomberg
JPM
Earnings
- 4/12/24 - Beat
JPM
Sec Filings
- 5/20/24 - Form 4
- 5/20/24 - Form 144
- 5/20/24 - Form 4
- JPM's page on the SEC website